ArticleNature cancer2026
The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.
Hye Mi Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature cancer2026
Hye Mi Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.